Location: Princeton, NJ
CIK: 0001388551 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 15, 2025
Total Value: $5.081M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RZLT | REZOLUTE INC | 1,318,967 | $3.825M | 75.3% | $9.52 | -54.3% | COM NEW | 76200L309 |
| GLD | SPDR GOLD TR | 1,298 | $374K | 7.4% | $246.72 | — | GOLD SHS | 78463V107 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 467 | $249K | 4.9% | $360.98 | +34.7% | CL B NEW | 084670702 |
| — | MIND MEDICINE MINDMED INC | 34,073 | $199K | 3.9% | $8.91 | — | COM NEW | 60255C885 |
| BCAX | BICARA THERAPEUTICS INC | 10,941 | $143K | 2.8% | $25.50 | -47.9% | COM | 055477103 |
| CMPX | COMPASS THERAPEUTICS INC | 43,465 | $82,584 | 1.6% | $3.23 | -17.7% | COM | 20454B104 |
| LXEO | LEXEO THERAPEUTICS INC | 17,851 | $61,943 | 1.2% | $13.31 | -66.7% | COM | 52886X107 |
| KYTX | KYVERNA THERAPEUTICS INC | 22,981 | $44,354 | 0.9% | $23.94 | -87.7% | COM | 501976104 |
| CRDF | CARDIFF ONCOLOGY INC | 13,287 | $41,721 | 0.8% | $3.13 | +26.5% | COM | 14147L108 |
| IKT | INHIBIKASE THERAPEUTICS INC | 16,393 | $35,901 | 0.7% | $2.49 | +0.7% | COM NEW | 45719W205 |
| — | ADICET BIO INC | 17,488 | $13,203 | 0.3% | $2.35 | — | COM | 007002108 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $11,263 | 0.2% | $1.72 | -49.5% | COM | 21077P108 |